Analysis | Metabolite Name | Measured Value | Units | Treatment | Minutes |
---|---|---|---|---|---|
GCMS positive ion mode | azelaic acid | 26 | Peak area | No GLP1/Late GTT | 0 |
GCMS positive ion mode | azelaic acid | 27 | Peak area | Early Fasting Insulin Infusion | 10 |
GCMS positive ion mode | azelaic acid | 30 | Peak area | GLP1 (High Dose) | 60 |
GCMS positive ion mode | azelaic acid | 33 | Peak area | GLP1 (High Dose) | 10 |
GCMS positive ion mode | azelaic acid | 46 | Peak area | Pool1 | |
GCMS positive ion mode | azelaic acid | 48 | Peak area | Late Fasting Insulin Infusion | 10 |
GCMS positive ion mode | azelaic acid | 56 | Peak area | GLP1 (High Dose) | 30 |
GCMS positive ion mode | azelaic acid | 61 | Peak area | GLP1 (Low Dose) | 0 |
GCMS positive ion mode | azelaic acid | 64 | Peak area | Late Fasting Insulin Infusion | 10 |
GCMS positive ion mode | azelaic acid | 71 | Peak area | No GLP1/Late GTT | 60 |
GCMS positive ion mode | azelaic acid | 82 | Peak area | Late Fasting Insulin Infusion | 10 |
GCMS positive ion mode | azelaic acid | 88 | Peak area | GLP1 (High Dose) | 120 |
GCMS positive ion mode | azelaic acid | 89 | Peak area | GLP1 (High Dose) | 30 |
GCMS positive ion mode | azelaic acid | 90 | Peak area | Late Fasting Insulin Infusion | 0 |
GCMS positive ion mode | azelaic acid | 90 | Peak area | No GLP1/Late GTT | 30 |
GCMS positive ion mode | azelaic acid | 91 | Peak area | Early Fasting Insulin Infusion | 0 |
GCMS positive ion mode | azelaic acid | 99 | Peak area | GLP1 (High Dose) | 0 |
GCMS positive ion mode | azelaic acid | 105 | Peak area | Early Fasting Insulin Infusion | 30 |
GCMS positive ion mode | azelaic acid | 105 | Peak area | No GLP1/Late GTT | 60 |
GCMS positive ion mode | azelaic acid | 106 | Peak area | GLP1 (Low Dose) | 120 |
GCMS positive ion mode | azelaic acid | 108 | Peak area | Early Fasting Insulin Infusion | 0 |
GCMS positive ion mode | azelaic acid | 110 | Peak area | Early Fasting Insulin Infusion | 0 |
GCMS positive ion mode | azelaic acid | 111 | Peak area | GLP1 (Low Dose) | 60 |
GCMS positive ion mode | azelaic acid | 112 | Peak area | Early Fasting Insulin Infusion | 30 |
GCMS positive ion mode | azelaic acid | 113 | Peak area | Early Fasting Insulin Infusion | 0 |
GCMS positive ion mode | azelaic acid | 113 | Peak area | Early Fasting Insulin Infusion | 120 |
GCMS positive ion mode | azelaic acid | 114 | Peak area | GLP1 (High Dose) | 60 |
GCMS positive ion mode | azelaic acid | 114 | Peak area | Late Fasting Insulin Infusion | 10 |
GCMS positive ion mode | azelaic acid | 118 | Peak area | Early Fasting Insulin Infusion | 10 |
GCMS positive ion mode | azelaic acid | 118 | Peak area | Early Fasting Insulin Infusion | 120 |
GCMS positive ion mode | azelaic acid | 120 | Peak area | Late Fasting Insulin Infusion | 0 |
GCMS positive ion mode | azelaic acid | 121 | Peak area | No GLP1/Late GTT | 30 |
GCMS positive ion mode | azelaic acid | 122 | Peak area | GLP1 (High Dose) | 120 |
GCMS positive ion mode | azelaic acid | 123 | Peak area | Early Fasting Insulin Infusion | 30 |
GCMS positive ion mode | azelaic acid | 123 | Peak area | No GLP1/Late GTT | 10 |
GCMS positive ion mode | azelaic acid | 123 | Peak area | No GLP1/Late GTT | 60 |
GCMS positive ion mode | azelaic acid | 128 | Peak area | Late Fasting Insulin Infusion | 10 |
GCMS positive ion mode | azelaic acid | 129 | Peak area | Early Fasting Insulin Infusion | 60 |
GCMS positive ion mode | azelaic acid | 132 | Peak area | No GLP1/Late GTT | 30 |
GCMS positive ion mode | azelaic acid | 133 | Peak area | Late Fasting Insulin Infusion | 60 |
GCMS positive ion mode | azelaic acid | 133 | Peak area | No GLP1/Late GTT | 0 |
GCMS positive ion mode | azelaic acid | 134 | Peak area | Late Fasting Insulin Infusion | 60 |
GCMS positive ion mode | azelaic acid | 135 | Peak area | GLP1 (High Dose) | 0 |
GCMS positive ion mode | azelaic acid | 136 | Peak area | No GLP1/Late GTT | 120 |
GCMS positive ion mode | azelaic acid | 137 | Peak area | No GLP1/Late GTT | 30 |
GCMS positive ion mode | azelaic acid | 140 | Peak area | Late Fasting Insulin Infusion | 30 |
GCMS positive ion mode | azelaic acid | 142 | Peak area | Early Fasting Insulin Infusion | 10 |
GCMS positive ion mode | azelaic acid | 142 | Peak area | GLP1 (Low Dose) | 30 |
GCMS positive ion mode | azelaic acid | 142 | Peak area | Late Fasting Insulin Infusion | 0 |
GCMS positive ion mode | azelaic acid | 143 | Peak area | Late Fasting Insulin Infusion | 30 |
GCMS positive ion mode | azelaic acid | 144 | Peak area | Early Fasting Insulin Infusion | 120 |
GCMS positive ion mode | azelaic acid | 144 | Peak area | GLP1 (Low Dose) | 30 |
GCMS positive ion mode | azelaic acid | 145 | Peak area | Early Fasting Insulin Infusion | 30 |
GCMS positive ion mode | azelaic acid | 147 | Peak area | Late Fasting Insulin Infusion | 60 |
GCMS positive ion mode | azelaic acid | 150 | Peak area | Early Fasting Insulin Infusion | 10 |
GCMS positive ion mode | azelaic acid | 152 | Peak area | Early Fasting Insulin Infusion | 120 |
GCMS positive ion mode | azelaic acid | 154 | Peak area | Early Fasting Insulin Infusion | 0 |
GCMS positive ion mode | azelaic acid | 155 | Peak area | Early Fasting Insulin Infusion | 10 |
GCMS positive ion mode | azelaic acid | 156 | Peak area | Early Fasting Insulin Infusion | 60 |
GCMS positive ion mode | azelaic acid | 157 | Peak area | No GLP1/Late GTT | 10 |
GCMS positive ion mode | azelaic acid | 158 | Peak area | GLP1 (Low Dose) | 10 |
GCMS positive ion mode | azelaic acid | 159 | Peak area | Early Fasting Insulin Infusion | 30 |
GCMS positive ion mode | azelaic acid | 167 | Peak area | GLP1 (High Dose) | 30 |
GCMS positive ion mode | azelaic acid | 167 | Peak area | Late Fasting Insulin Infusion | 60 |
GCMS positive ion mode | azelaic acid | 169 | Peak area | No GLP1/Late GTT | 10 |
GCMS positive ion mode | azelaic acid | 175 | Peak area | No GLP1/Late GTT | 120 |
GCMS positive ion mode | azelaic acid | 177 | Peak area | GLP1 (High Dose) | 10 |
GCMS positive ion mode | azelaic acid | 177 | Peak area | No GLP1/Late GTT | 120 |
GCMS positive ion mode | azelaic acid | 181 | Peak area | GLP1 (Low Dose) | 120 |
GCMS positive ion mode | azelaic acid | 184 | Peak area | GLP1 (Low Dose) | 30 |
GCMS positive ion mode | azelaic acid | 185 | Peak area | GLP1 (Low Dose) | 60 |
GCMS positive ion mode | azelaic acid | 188 | Peak area | GLP1 (High Dose) | 10 |
GCMS positive ion mode | azelaic acid | 188 | Peak area | Late Fasting Insulin Infusion | 120 |
GCMS positive ion mode | azelaic acid | 189 | Peak area | GLP1 (Low Dose) | 10 |
GCMS positive ion mode | azelaic acid | 190 | Peak area | GLP1 (High Dose) | 30 |
GCMS positive ion mode | azelaic acid | 191 | Peak area | Pool3 | |
GCMS positive ion mode | azelaic acid | 192 | Peak area | Late Fasting Insulin Infusion | 30 |
GCMS positive ion mode | azelaic acid | 193 | Peak area | GLP1 (High Dose) | 60 |
GCMS positive ion mode | azelaic acid | 194 | Peak area | Early Fasting Insulin Infusion | 120 |
GCMS positive ion mode | azelaic acid | 197 | Peak area | Pool3 | |
GCMS positive ion mode | azelaic acid | 199 | Peak area | GLP1 (Low Dose) | 60 |
GCMS positive ion mode | azelaic acid | 200 | Peak area | Late Fasting Insulin Infusion | 0 |
GCMS positive ion mode | azelaic acid | 200 | Peak area | No GLP1/Late GTT | 60 |
GCMS positive ion mode | azelaic acid | 201 | Peak area | GLP1 (High Dose) | 0 |
GCMS positive ion mode | azelaic acid | 205 | Peak area | No GLP1/Late GTT | 10 |
GCMS positive ion mode | azelaic acid | 206 | Peak area | GLP1 (High Dose) | 60 |
GCMS positive ion mode | azelaic acid | 206 | Peak area | Late Fasting Insulin Infusion | 120 |
GCMS positive ion mode | azelaic acid | 208 | Peak area | No GLP1/Late GTT | 120 |
GCMS positive ion mode | azelaic acid | 210 | Peak area | No GLP1/Late GTT | 60 |
GCMS positive ion mode | azelaic acid | 213 | Peak area | Pool2 | |
GCMS positive ion mode | azelaic acid | 217 | Peak area | Early Fasting Insulin Infusion | 60 |
GCMS positive ion mode | azelaic acid | 218 | Peak area | No GLP1/Late GTT | 120 |
GCMS positive ion mode | azelaic acid | 220 | Peak area | GLP1 (High Dose) | 120 |
GCMS positive ion mode | azelaic acid | 220 | Peak area | GLP1 (Low Dose) | 120 |
GCMS positive ion mode | azelaic acid | 221 | Peak area | Pool2 | |
GCMS positive ion mode | azelaic acid | 228 | Peak area | No GLP1/Late GTT | 0 |
GCMS positive ion mode | azelaic acid | 235 | Peak area | GLP1 (High Dose) | 120 |
GCMS positive ion mode | azelaic acid | 236 | Peak area | No GLP1/Late GTT | 30 |
GCMS positive ion mode | azelaic acid | 244 | Peak area | Late Fasting Insulin Infusion | 0 |
GCMS positive ion mode | azelaic acid | 246 | Peak area | GLP1 (Low Dose) | 0 |
GCMS positive ion mode | azelaic acid | 248 | Peak area | No GLP1/Late GTT | 10 |
GCMS positive ion mode | azelaic acid | 252 | Peak area | Late Fasting Insulin Infusion | 120 |
GCMS positive ion mode | azelaic acid | 253 | Peak area | GLP1 (Low Dose) | 0 |
GCMS positive ion mode | azelaic acid | 256 | Peak area | Pool2 | |
GCMS positive ion mode | azelaic acid | 272 | Peak area | Late Fasting Insulin Infusion | 30 |
GCMS positive ion mode | azelaic acid | 281 | Peak area | Pool1 | |
GCMS positive ion mode | azelaic acid | 285 | Peak area | No GLP1/Late GTT | 0 |
GCMS positive ion mode | azelaic acid | 290 | Peak area | GLP1 (High Dose) | 0 |
GCMS positive ion mode | azelaic acid | 290 | Peak area | Late Fasting Insulin Infusion | 30 |
GCMS positive ion mode | azelaic acid | 290 | Peak area | Pool3 | |
GCMS positive ion mode | azelaic acid | 310 | Peak area | Pool1 | |
GCMS positive ion mode | azelaic acid | 313 | Peak area | Late Fasting Insulin Infusion | 120 |
GCMS positive ion mode | azelaic acid | 325 | Peak area | GLP1 (High Dose) | 10 |
GCMS positive ion mode | azelaic acid | 344 | Peak area | No GLP1/Late GTT | 0 |
GCMS positive ion mode | azelaic acid | 370 | Peak area | Early Fasting Insulin Infusion | 60 |
GCMS positive ion mode | azelaic acid | 439 | Peak area | Late Fasting Insulin Infusion | 120 |